Last reviewed · How we verify
Normal Nicotine Content Cigarettes
Normal nicotine content cigarettes deliver standard levels of nicotine to study the relationship between nicotine exposure and smoking behavior or health outcomes in a controlled research setting.
Normal nicotine content cigarettes deliver standard levels of nicotine to study the relationship between nicotine exposure and smoking behavior or health outcomes in a controlled research setting. Used for Nicotine dependence research, Smoking behavior modification studies.
At a glance
| Generic name | Normal Nicotine Content Cigarettes |
|---|---|
| Also known as | Conventional Nicotine Content Cigarettes |
| Sponsor | University of Minnesota |
| Target | Nicotinic acetylcholine receptors |
| Modality | Small molecule |
| Therapeutic area | Addiction Medicine / Smoking Cessation |
| Phase | Phase 3 |
Mechanism of action
This appears to be a research product from the University of Minnesota designed as a control or comparison arm in smoking behavior studies. Normal nicotine cigarettes serve as a baseline to compare against reduced-nicotine or modified cigarettes in Phase 3 trials examining nicotine dependence, smoking cessation, or harm reduction strategies.
Approved indications
- Nicotine dependence research
- Smoking behavior modification studies
Common side effects
- Nicotine dependence
- Cardiovascular effects
- Respiratory irritation
Key clinical trials
- Opioids, Low Nicotine Cigarettes, and Chronic Pain (NA)
- Impact of Nicotine Messaging on Beliefs and Behavior (NA)
- Effect of Smoking on Retinal Vessel Morphology and Functionality (NA)
- Low Nicotine Cigarettes Plus Electronic Cigarettes (NA)
- Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing (NA)
- Low Nicotine Cigarettes, Smoking, and Chronic Pain (NA)
- Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes (PHASE2)
- Low Nicotine Content Cigarettes in Vulnerable Populations: Affective Disorders (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |